NeuroBo Pharmaceuticals Inc (NRBO)

[crudeoil24]

PAIN RELIEF > SAFETY > NO SIDE EFFECTS & BIOMAKER TO MONITOR PROGRESSION >>>>> "In addition to pain alleviation, preclinical work on NB-01 has demonstrated effects on increasing the release of nerve growth factor (NGF), stimulating nerve growth, and inhibiting advanced glycation end-products (AGEs) and inflammatory markers. “While today’s approved drugs to treat diabetic neuropathic pain simply alleviate symptoms, they have a range of side effects and, unlike NB-01, do not address the underlying nerve damage in patients,” said Mark Versavel, MD, PhD, MBA, chief medical officer, NeuroBo Pharmaceuticals. “While our initial objective is to confirm the Phase 2 results on pain improvement, we believe that NB-01 has a strong potential to be a disease-modifying therapy, and we hope to differentiate our drug from other pain treatments with additional biomarker work to monitor and assess disease progression."